CDMO CASE STUDY AJILITY: Streamlining Drug Product Manufacturing

摘要

In the current pandemic landscape, there is an increased focus on faster turnaround times. As drug developers race to get these critical therapies into the clinic and subsequently into commercial production, they are expediting the CDMO selection process along with tightening timelines for tech transfer, and the preparation and release process for fills.